Vitamin B6 and Vitamin E: study protocols
13 study groups took Vitamin B6 together with Vitamin E. These are the doses the studies gave. They are not a recommendation.
Dose per serving from research: Vitamin B6
13 study groups in 11 studies say how much Vitamin B6 participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 10 mg to 25 mg, 23% of 13 study groups.
| Daily dose | Study groups |
|---|---|
| 500 mcg to 1 mg | 2 |
| 1 mg to 2.5 mg | 2 |
| 2.5 mg to 5 mg | 1 |
| 5 mg to 10 mg | 1 |
| 10 mg to 25 mg | 3 |
| 25 mg to 50 mg | 2 |
| 50 mg to 100 mg | 2 |
Dose per serving from research: Vitamin E
10 study groups in 8 studies say how much Vitamin E participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 25 mg to 50 mg, 40% of 10 study groups.
| Daily dose | Study groups |
|---|---|
| 5 mg to 10 mg | 2 |
| 10 mg to 25 mg | 2 |
| 25 mg to 50 mg | 4 |
| 50 mg to 100 mg | 1 |
| 100 mg to 250 mg | 0 |
| over 250 mg | 1 |
Commonly used together
13 of 13 study groups took Vitamin B6 and Vitamin E with something else. Shown: what 3 or more different studies gave.
What was given together, not what works together.
| Taken with | Study groups |
|---|---|
| Vitamin B12 | 11 |
| Vitamin C | 10 |
| Folic Acid | 9 |
| Riboflavin | 7 |
| Thiamine | 7 |
| Zinc | 5 |
| Vitamin A | 4 |
| Niacin | 3 |
13 study groups
| Study | ||||
|---|---|---|---|---|
| Megadose vitamins in bladder cancer: a double-blind clinical trial 1994 · megadose vitamins arm · Patients with biopsy-confirmed transitional cell carcinoma of the bladder receiving BCG immunotherapy | 100 mg | — | — | 35 |
| Effects of multimicronutrient supplementation on helminth reinfection: a randomized, controlled trial in Kenyan schoolchildren 2003 · multimicronutrient supplementation · Schoolchildren in Nyanza Province, Kenya; age and sex not specified | 1.7 mg | 8 mg | 335 days | — |
| Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal 2003 · Multiple micronutrients · Pregnant women in rural Nepal | 2.2 mg | 10 mg | — | — |
| Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension 2005 · Multivitamin plus vitamin A · HIV-positive pregnant Tanzanian women | 25 mg | 30 mg | — | — |
| Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension 2005 · Multivitamin without vitamin A · HIV-positive pregnant Tanzanian women | 25 mg | 30 mg | — | — |
| Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy 2024 · 10-element combination tablet · Overweight or obese adults with type 2 diabetes and mild-to-moderate painful diabetic neuropathy; mean age 63 years | 3 mg | 15 mg | 26 weeks | 36 |
| A functional evaluation of anti-fatigue and exercise performance improvement following vitamin B complex supplementation in healthy humans, a randomized double-blind trial 2023 · Ex PLUS® group · Healthy male and female non-athletes aged 20–30 | 50 mg | 16.8 mg | 4 weeks | 32 |
| Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation 2011 · Group MVB · Patients with type 2 diabetes | 10 mg | 100 mg | 120 days | — |
| Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease 2015 · Active group (RCT1, RCT2 and RCT3) · Men and women aged 50 years or older with mild or mild-to-moderate Alzheimer's disease; RCT3 participants were on stable approved Alzheimer's medication, while RCT1 and RCT2 participants were drug-free for Alzheimer's medication. | 1 mg | 40 mg | 24 weeks | 501 |
| Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease 2015 · Active product during open-label extension (OLE) · Men and women aged 50 years or older with mild Alzheimer's disease who completed RCT2. | 1 mg | 40 mg | 24 weeks | 201 |
| Supplementation with antioxidant micronutrients in pregnant women with obesity: a randomized controlled trial 2024 · Intervention group · Pregnant women with obesity (BMI ≥30 kg/m²) | 18 mg | — | — | 64 |
| Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial 2006 · Antioxidant vitamins plus B-group vitamins · Acute ischemic stroke patients treated within 12 hours of symptom onset | 50 mg | 800 IU | 2 weeks | 24 |
| Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD 2009 · Treatment group · Adults with stage 2 to 4 chronic kidney disease and creatinine clearance of 15 to 70 mL/min/1.73 m² | 100 mg | 300 mg | 2 years | 47 |